An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

Clinical trial NCT07063251 · RECRUITING

Trial details

NCT number: NCT07063251
Sponsor: HuidaGene Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stargardt Disease Type 1 (STGD1)

Start date: 2025-08-20
Primary completion: 2027-02-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.